(Reuters) - "We are in regular dialogue with our investors and do listen
to the views they express," a GlaxoSmithKline spokesman
said.
"We continue to believe that Consumer Healthcare is an
important part of GSK providing long-term value through
sustained revenues, new product opportunities and synergistic Rx
to OTC switches, such as the
recent launch of Alli."
Read more at Reuters.com Mergers News
to the views they express," a GlaxoSmithKline spokesman
said.
"We continue to believe that Consumer Healthcare is an
important part of GSK providing long-term value through
sustained revenues, new product opportunities and synergistic Rx
to OTC switches, such as the
recent launch of Alli."
Read more at Reuters.com Mergers News
No comments:
Post a Comment